Junevity
Operator of a biotechnology company intended to develop cell reset therapeutics for longevity. The company's platform uses large-scale human data and artificial intelligence to identify transcription ...
Valuation
$0
Share Price
N/A
Total Raised
$20M
Last Round
Unknown
Latest Funding Round
Unknown
Investors
+8 other investors